{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T17:16:24Z","timestamp":1788542184294,"version":"build-2803163510"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["ZIA BC 011657"],"award-info":[{"award-number":["ZIA BC 011657"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy Nucleic Acids"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.omtn.2021.04.001","type":"journal-article","created":{"date-parts":[[2021,4,3]],"date-time":"2021-04-03T20:09:59Z","timestamp":1617480599000},"page":"669-681","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["MicroRNA-206 suppresses mesothelioma progression via the Ras signaling axis"],"prefix":"10.1016","volume":"24","author":[{"given":"Anand","family":"Singh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathanael","family":"Pruett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roma","family":"Pahwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arushi P.","family":"Mahajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3613-1400","authenticated-orcid":false,"given":"David S.","family":"Schrump","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4016-1434","authenticated-orcid":false,"given":"Chuong D.","family":"Hoang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtn.2021.04.001_bib1","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.lungcan.2015.03.005","article-title":"Demographics, management and survival of patients with malignant pleural mesothelioma in the National Lung Cancer Audit in England and Wales","volume":"88","author":"Beckett","year":"2015","journal-title":"Lung Cancer"},{"key":"10.1016\/j.omtn.2021.04.001_bib2","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/S0140-6736(15)01238-6","article-title":"Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial","volume":"387","author":"Zalcman","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.omtn.2021.04.001_bib3","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/ng.3520","article-title":"Comprehensive genomic analysis of malignant pleural mesothelioma identifies recurrent mutations, gene fusions and splicing alterations","volume":"48","author":"Bueno","year":"2016","journal-title":"Nat. Genet."},{"key":"10.1016\/j.omtn.2021.04.001_bib4","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1177\/1947601910375273","article-title":"A phosphotyrosine proteomic screen identifies multiple tyrosine kinase signaling pathways aberrantly activated in malignant mesothelioma","volume":"1","author":"Menges","year":"2010","journal-title":"Genes Cancer"},{"key":"10.1016\/j.omtn.2021.04.001_bib5","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1038\/bjc.2014.220","article-title":"Multipoint targeting of the PI3K\/mTOR pathway in mesothelioma","volume":"110","author":"Zhou","year":"2014","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.omtn.2021.04.001_bib6","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1158\/2159-8290.CD-18-0804","article-title":"Integrative molecular characterization of malignant pleural mesothelioma","volume":"8","author":"Hmeljak","year":"2018","journal-title":"Cancer Discov."},{"key":"10.1016\/j.omtn.2021.04.001_bib7","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1097\/JTO.0b013e31811f3aab","article-title":"Ras pathway activation in malignant mesothelioma","volume":"2","author":"Patel","year":"2007","journal-title":"J.\u00a0Thorac. Oncol."},{"key":"10.1016\/j.omtn.2021.04.001_bib8","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1200\/JCO.2016.69.0032","article-title":"Cell-cycle therapeutics come of age","volume":"35","author":"Ingham","year":"2017","journal-title":"J.\u00a0Clin. Oncol."},{"key":"10.1016\/j.omtn.2021.04.001_bib9","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3389\/fonc.2020.00343","article-title":"Emerging treatments for malignant pleural mesothelioma: where are we heading?","volume":"10","author":"Cantini","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.omtn.2021.04.001_bib10","series-title":"Malignant Pleural Mesothelioma Guidelines","year":"2020"},{"key":"10.1016\/j.omtn.2021.04.001_bib11","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1073\/pnas.0307323101","article-title":"Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers","volume":"101","author":"Calin","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtn.2021.04.001_bib12","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.ebiom.2016.09.017","article-title":"microRNA therapeutics in cancer\u2014an emerging concept","volume":"12","author":"Shah","year":"2016","journal-title":"EBioMedicine"},{"key":"10.1016\/j.omtn.2021.04.001_bib13","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrd.2016.246","article-title":"MicroRNA therapeutics: towards a new era for the management of cancer and other diseases","volume":"16","author":"Rupaimoole","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.omtn.2021.04.001_bib14","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1016\/S1470-2045(17)30621-6","article-title":"Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study","volume":"18","author":"van Zandwijk","year":"2017","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.omtn.2021.04.001_bib15","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.3390\/ijms19061603","article-title":"Heterogeneity in malignant pleural mesothelioma","volume":"19","author":"Oehl","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.omtn.2021.04.001_bib16","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1378\/chest.12-2770","article-title":"miR-1 induces growth arrest and apoptosis in malignant mesothelioma","volume":"144","author":"Xu","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.omtn.2021.04.001_bib17","doi-asserted-by":"crossref","first-page":"e1006244","DOI":"10.1371\/journal.pgen.1006244","article-title":"Reprogramming of normal fibroblasts into cancer-associated fibroblasts by miRNAs-mediated CCL2\/VEGFA signaling","volume":"12","author":"Shen","year":"2016","journal-title":"PLoS Genet."},{"key":"10.1016\/j.omtn.2021.04.001_bib18","doi-asserted-by":"crossref","first-page":"4867","DOI":"10.1038\/onc.2014.408","article-title":"MicroRNA-206 functions as a pleiotropic modulator of cell proliferation, invasion and lymphangiogenesis in pancreatic adenocarcinoma by targeting ANXA2 and KRAS genes","volume":"34","author":"Keklikoglou","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.omtn.2021.04.001_bib19","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/pcmr.12200","article-title":"MicroRNA-206 induces G1 arrest in melanoma by inhibition of CDK4 and Cyclin D","volume":"27","author":"Georgantas","year":"2014","journal-title":"Pigment Cell Melanoma Res."},{"key":"10.1016\/j.omtn.2021.04.001_bib20","doi-asserted-by":"crossref","first-page":"L652","DOI":"10.1152\/ajplung.00141.2020","article-title":"Normal mesothelial cell lines newly derived from human pleural biopsy explants","volume":"319","author":"Pruett","year":"2020","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"issue":"D1","key":"10.1016\/j.omtn.2021.04.001_bib21","doi-asserted-by":"crossref","first-page":"D296","DOI":"10.1093\/nar\/gkx1067","article-title":"miRTarBase update 2018: a resource for experimentally validated microRNA-target interactions","volume":"46","author":"Chou","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2021.04.001_bib22","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1093\/jnci\/djq102","article-title":"MicroRNA cluster 221-222 and estrogen receptor alpha interactions in breast cancer","volume":"102","author":"Di Leva","year":"2010","journal-title":"J.\u00a0Natl. Cancer Inst."},{"key":"10.1016\/j.omtn.2021.04.001_bib23","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.1093\/nar\/gkr1222","article-title":"MicroRNA-1 is a candidate tumor suppressor and prognostic marker in human prostate cancer","volume":"40","author":"Hudson","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2021.04.001_bib24","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/2045-3701-4-26","article-title":"MicroRNA-206 suppresses gastric cancer cell growth and metastasis","volume":"4","author":"Ren","year":"2014","journal-title":"Cell Biosci."},{"key":"10.1016\/j.omtn.2021.04.001_bib25","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.canlet.2013.01.023","article-title":"miR-206 inhibits gastric cancer proliferation in part by repressing cyclinD2","volume":"332","author":"Zhang","year":"2013","journal-title":"Cancer Lett."},{"key":"10.1016\/j.omtn.2021.04.001_bib26","doi-asserted-by":"crossref","first-page":"182","DOI":"10.3389\/fphys.2017.00182","article-title":"Skeletal muscle myomiR are differentially expressed by endurance exercise mode and combined essential amino acid and carbohydrate supplementation","volume":"8","author":"Margolis","year":"2017","journal-title":"Front. Physiol."},{"key":"10.1016\/j.omtn.2021.04.001_bib27","doi-asserted-by":"crossref","first-page":"e113","DOI":"10.1038\/oncsis.2014.26","article-title":"Selective repression of the oncogene cyclin D1 by the tumor suppressor miR-206 in cancers","volume":"3","author":"Elliman","year":"2014","journal-title":"Oncogenesis"},{"key":"10.1016\/j.omtn.2021.04.001_bib28","doi-asserted-by":"crossref","first-page":"e05005","DOI":"10.7554\/eLife.05005","article-title":"Predicting effective microRNA target sites in mammalian mRNAs","volume":"4","author":"Agarwal","year":"2015","journal-title":"eLife"},{"key":"10.1016\/j.omtn.2021.04.001_bib29","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1016\/j.cell.2006.07.031","article-title":"A pattern-based method for the identification of MicroRNA binding sites and their corresponding heteroduplexes","volume":"126","author":"Miranda","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.omtn.2021.04.001_bib30","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.cancergen.2013.04.006","article-title":"Integrated high-resolution array CGH and SKY analysis of homozygous deletions and other genomic alterations present in malignant mesothelioma cell lines","volume":"206","author":"Klorin","year":"2013","journal-title":"Cancer Genet."},{"key":"10.1016\/j.omtn.2021.04.001_bib31","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1016\/j.ymthe.2019.05.020","article-title":"MicroRNA-215-5p treatment suppresses mesothelioma progression via the MDM2-p53-signaling axis","volume":"27","author":"Singh","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtn.2021.04.001_bib32","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.cels.2016.06.006","article-title":"Causal mechanistic regulatory network for glioblastoma deciphered using systems genetics network analysis","volume":"3","author":"Plaisier","year":"2016","journal-title":"Cell Syst."},{"issue":"D1","key":"10.1016\/j.omtn.2021.04.001_bib33","doi-asserted-by":"crossref","first-page":"D127","DOI":"10.1093\/nar\/gkz757","article-title":"miRDB: an online database for prediction of functional microRNA targets","volume":"48","author":"Chen","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.omtn.2021.04.001_bib34","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1186\/gb-2003-5-1-r1","article-title":"MicroRNA targets in Drosophila","volume":"5","author":"Enright","year":"2003","journal-title":"Genome Biol."},{"key":"10.1016\/j.omtn.2021.04.001_bib35","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1093\/jjco\/hyz151","article-title":"Differences of cyclin-dependent kinase 4\/6 inhibitor, palbociclib and abemaciclib, in breast cancer","volume":"49","author":"Tamura","year":"2019","journal-title":"Jpn. J. Clin. Oncol."},{"key":"10.1016\/j.omtn.2021.04.001_bib36","first-page":"5334","article-title":"Asbestos causes stimulation of the extracellular signal-regulated kinase 1 mitogen-activated protein kinase cascade after phosphorylation of the epidermal growth factor receptor","volume":"56","author":"Zanella","year":"1996","journal-title":"Cancer Res."},{"key":"10.1016\/j.omtn.2021.04.001_bib37","doi-asserted-by":"crossref","first-page":"6370","DOI":"10.1038\/s41388-019-0883-6","article-title":"The NF2 tumor suppressor merlin interacts with Ras and RasGAP, which may modulate Ras signaling","volume":"38","author":"Cui","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.omtn.2021.04.001_bib38","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.lungcan.2012.02.022","article-title":"Exploratory analysis of activation of PTEN-PI3K pathway and downstream proteins in malignant pleural mesothelioma (MPM)","volume":"77","author":"Cedr\u00e9s","year":"2012","journal-title":"Lung Cancer"},{"key":"10.1016\/j.omtn.2021.04.001_bib39","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.3389\/fonc.2019.01199","article-title":"RAS as supporting actor in breast cancer","volume":"9","author":"Gali\u00e8","year":"2019","journal-title":"Front. Oncol."},{"key":"10.1016\/j.omtn.2021.04.001_bib40","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S2213-2600(19)30139-0","article-title":"Nintedanib in combination with pemetrexed and cisplatin for chemotherapy-naive patients with advanced malignant pleural mesothelioma (LUME-Meso): a double-blind, randomised, placebo-controlled phase 3 trial","volume":"7","author":"Scagliotti","year":"2019","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.omtn.2021.04.001_bib41","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/cpt.126","article-title":"The signature program: bringing the protocol to the patient","volume":"98","author":"Kang","year":"2015","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.omtn.2021.04.001_bib42","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.neo.2017.05.003","article-title":"Combined inhibition of CDK4\/6 and PI3K\/AKT\/mTOR pathways induces a synergistic anti-tumor effect in malignant pleural mesothelioma cells","volume":"19","author":"Bonelli","year":"2017","journal-title":"Neoplasia"},{"key":"10.1016\/j.omtn.2021.04.001_bib43","doi-asserted-by":"crossref","first-page":"S343","DOI":"10.1016\/j.jtho.2019.08.692","article-title":"MA23.02 CDK4\/6 inhibitors show antitumor effects in preclinical models of malignant pleural mesothelioma","volume":"14","author":"Aliagas","year":"2019","journal-title":"J.\u00a0Thorac. Oncol."},{"key":"10.1016\/j.omtn.2021.04.001_bib44","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1210\/me.2015-1157","article-title":"Minireview: were the IGF signaling inhibitors all bad?","volume":"29","author":"Beckwith","year":"2015","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.omtn.2021.04.001_bib45","doi-asserted-by":"crossref","first-page":"2730","DOI":"10.1021\/mp4001662","article-title":"Synergistic combination of small molecule inhibitor and RNA interference against antiapoptotic Bcl-2 protein in head and neck cancer cells","volume":"10","author":"Lin","year":"2013","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.omtn.2021.04.001_bib46","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13045-020-00880-8","article-title":"The application and prospect of CDK4\/6 inhibitors in malignant solid tumors","volume":"13","author":"Du","year":"2020","journal-title":"J.\u00a0Hematol. Oncol."},{"key":"10.1016\/j.omtn.2021.04.001_bib47","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3390\/cells8040321","article-title":"Updates on the CDK4\/6 inhibitory strategy and combinations in breast cancer","volume":"8","author":"Sobhani","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.omtn.2021.04.001_bib48","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1136\/thoraxjnl-2015-207496","article-title":"MesobanK UK: an international mesothelioma bioresource","volume":"71","author":"Rintoul","year":"2016","journal-title":"Thorax"},{"key":"10.1016\/j.omtn.2021.04.001_bib49","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2\u2212\u0394\u0394Ct method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.omtn.2021.04.001_bib50","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ccr.2011.07.018","article-title":"The glycolytic shift in fumarate-hydratase-deficient kidney cancer lowers AMPK levels, increases anabolic propensities and lowers cellular iron levels","volume":"20","author":"Tong","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.omtn.2021.04.001_bib51","doi-asserted-by":"crossref","first-page":"6477","DOI":"10.4049\/jimmunol.174.10.6477","article-title":"Human lymphoid and myeloid cell development in NOD\/LtSz-scid IL2R gamma null mice engrafted with mobilized human hemopoietic stem cells","volume":"174","author":"Shultz","year":"2005","journal-title":"J.\u00a0Immunol."}],"container-title":["Molecular Therapy Nucleic Acids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253121000949?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2162253121000949?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T16:44:36Z","timestamp":1788540276000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2162253121000949"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":51,"alternative-id":["S2162253121000949"],"URL":"https:\/\/doi.org\/10.1016\/j.omtn.2021.04.001","relation":{},"ISSN":["2162-2531"],"issn-type":[{"value":"2162-2531","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MicroRNA-206 suppresses mesothelioma progression via the Ras signaling axis","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy Nucleic Acids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtn.2021.04.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"name":"copyright","label":"Copyright"}]}}